Aluminum, the most commonly used vaccine adjuvant,1 may be increasing the risk of asthma in children when injected as part of the standard childhood vaccine schedule. The finding comes from a study funded by the U.S. Centers for Disease Control and Prevention (CDC), raising concerns about the cumulative aluminum exposure children receive when they get… Read More: Aluminum in Vaccines Linked to Persistent Asthma »
Print this page London UK 9 September 2020 — GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol ‘FF/UMEC/VI’) for the treatment of asthma in patients aged 18 years and older adding to… Read More: FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of… »
Asthma affects approximately 20 million adults in the US. It is a common cause of workplace and school absenteeism, and is one of the leading causes of hospitalizations in the US. Between 5% and 10% of asthmatics have frequent, persistent symptoms despite treatment with multiple medications, and are categorized as “difficult to treat” and “severe”… Read More: Triple therapy helps control severe asthma »
WEDNESDAY, Aug. 19, 2020 — High levels of air pollution may increase young children’s risk of developing asthma and persistent wheezing, researchers warn. The findings “support emerging evidence that exposure to air pollution might influence the development of asthma,” according to a report by Torben Sigsgaard, of Aarhus University in Denmark, and colleagues. For the… Read More: Air Pollution Tied to Asthma in Young Kids »